A conversation with Dr. Jason H. Moore from Cedars-Sinai Medical Center about the coming impact of artificial intelligence on a spectrum of Alzheimer’s disease and related dementia (ADRD) issues.
A conversation with Dr. Joanne Spetz about who makes up the professional workforce of people who provide dementia care and how these individuals play a critical role in the delivery of services.
A conversation with Rush University’s Dr. Lisa Barnes, who talks with Matt and Donovan about racial disparities in dementia and several obstacles that have impeded our understanding of race and dementia.
A conversation with University of Michigan researcher, Dr. Vinod Vydiswaran, who’s been developing methods to identify dementia from EHR data.
A conversation with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
A conversation with University of Michigan epidemiologist Dr. Lindsay Kobayashi about her research on the social epidemiology of aging from a global perspective.
Matt and Donovan talk with Dr. Lauren Hunt from UCSF, an expert in hospice care for persons living with dementia, about dementia at the end of life.
In this episode, Matt & Donovan speak with University of Michigan faculty member, Sue Anne Bell, about how healthcare disruption due to a disaster can affect the population of older adults living with dementia.
In this episode of Minding Memory, we dive into the newest FDA-approved drug to treat Alzheimer’s – Lecanemab – with Ohio State University stroke neurologist Jim Burke.
Donovan and Matt talk with health services researcher Betsy White from Brown University about a unique new resource for researchers called the Long-Term Data Cooperative
Subscribe now to stay informed with the latest news and insights from CAPRA!